In today's podcast, I'm discussing a significant development in the healthcare compliance technology sector. Bluesight's recent acquisition of Protenus has created waves of concern among Protenus customers who now face an unexpected transition. While many were satisfied with their Protenus diversion software solutions, they're now being required to switch to Bluesight's platform. These customers are navigating negotiations with a new company while managing this mandated change. I'll share insights on why this matters, what customers are experiencing, and what options might be available moving forward in this rapidly consolidating industry.
Listen in for a 5-minute exploration of this timely topic that's affecting healthcare compliance departments across the industry.